
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis
Nuzrath Jahan, Adarsha Brahma, Muthusamy Santhosh Kumar, et al.
International Journal of Infectious Diseases (2021) Vol. 116, pp. 59-67
Open Access | Times Cited: 33
Nuzrath Jahan, Adarsha Brahma, Muthusamy Santhosh Kumar, et al.
International Journal of Infectious Diseases (2021) Vol. 116, pp. 59-67
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Stefan Pilz, Verena Theiler‐Schwetz, Christian Trummer, et al.
Environmental Research (2022) Vol. 209, pp. 112911-112911
Open Access | Times Cited: 232
Stefan Pilz, Verena Theiler‐Schwetz, Christian Trummer, et al.
Environmental Research (2022) Vol. 209, pp. 112911-112911
Open Access | Times Cited: 232
End COVID-19 in low- and middle-income countries
Ahmed Mushfiq Mobarak, Edward Miguel, Jason Abaluck, et al.
Science (2022) Vol. 375, Iss. 6585, pp. 1105-1110
Closed Access | Times Cited: 56
Ahmed Mushfiq Mobarak, Edward Miguel, Jason Abaluck, et al.
Science (2022) Vol. 375, Iss. 6585, pp. 1105-1110
Closed Access | Times Cited: 56
Sub-optimal neutralisation of omicron (B.1.1.529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months
Guruprasad R. Medigeshi, Gaurav Batra, Deepika Rathna Murugesan, et al.
EBioMedicine (2022) Vol. 78, pp. 103938-103938
Open Access | Times Cited: 54
Guruprasad R. Medigeshi, Gaurav Batra, Deepika Rathna Murugesan, et al.
EBioMedicine (2022) Vol. 78, pp. 103938-103938
Open Access | Times Cited: 54
Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India
T. S. Selvavinayagam, Anavarathan Somasundaram, Jerard Maria Selvam, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
T. S. Selvavinayagam, Anavarathan Somasundaram, Jerard Maria Selvam, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Mycobacterium tuberculosis growth inhibition by peripheral blood mononuclear cells from household contacts is not affected by previous SARS-CoV-2 infection
Jane Shaw, Charlotte Christie Petersen, Andriëtte Hiemstra, et al.
(2025)
Closed Access
Jane Shaw, Charlotte Christie Petersen, Andriëtte Hiemstra, et al.
(2025)
Closed Access
Sero-Surveillance to Evaluate Trends in the Transmission of SARS-CoV-2 in a Central Indian District
Pragati Rathod, Sarita Sharma, Ajaya Krishnan P, et al.
Cureus (2025)
Open Access
Pragati Rathod, Sarita Sharma, Ajaya Krishnan P, et al.
Cureus (2025)
Open Access
Mycobacterium tuberculosis growth inhibition by peripheral blood mononuclear cells from household contacts is not affected by previous SARS-CoV-2 infection
Jane Shaw, Charlotte Christie Petersen, Andriëtte Hiemstra, et al.
(2025)
Closed Access
Jane Shaw, Charlotte Christie Petersen, Andriëtte Hiemstra, et al.
(2025)
Closed Access
Impact of COVID-19 during pregnancy on placental pathology, maternal and neonatal outcome – A cross-sectional study on anemic term pregnant women from a tertiary care hospital in southern India
Surekha Venkata Mullapudi, Nadimpalli Suneetha, Nagalla Balakrishna, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 13
Surekha Venkata Mullapudi, Nadimpalli Suneetha, Nagalla Balakrishna, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 13
Pre-existing antibody levels negatively correlate with antibody titers after a single dose of BBV152 vaccination
Suman R. Das, Janmejay Singh, Heena Shaman, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Suman R. Das, Janmejay Singh, Heena Shaman, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Baroreflex sensitivity is impaired in survivors of mild COVID‐19 at 3–6 months of clinical recovery; association with carotid artery stiffness
Prachi Srivastava, P M Nabeel, Raj Kiran, et al.
Physiological Reports (2023) Vol. 11, Iss. 21
Open Access | Times Cited: 6
Prachi Srivastava, P M Nabeel, Raj Kiran, et al.
Physiological Reports (2023) Vol. 11, Iss. 21
Open Access | Times Cited: 6
Sub-optimal Neutralisation of Omicron (B.1.1.529) Variant by Antibodies induced by Vaccine alone or SARS-CoV-2 Infection plus Vaccine (Hybrid Immunity) post 6-months
Guruprasad R. Medigeshi, Gaurav Batra, Deepika Rathna Murugesan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 9
Guruprasad R. Medigeshi, Gaurav Batra, Deepika Rathna Murugesan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 9
Vaccine-elicited immune pressure and SARS-CoV-2 mutational dynamics in breakthrough infections
Sarwareddy Kartik Kumar, Srinivas Sathrasala, Jandhyala Sai Krishna, et al.
Gene Reports (2024) Vol. 35, pp. 101899-101899
Closed Access | Times Cited: 1
Sarwareddy Kartik Kumar, Srinivas Sathrasala, Jandhyala Sai Krishna, et al.
Gene Reports (2024) Vol. 35, pp. 101899-101899
Closed Access | Times Cited: 1
Utility of COVID-19 Seropositive Plasma as Convalescent Plasma: An Immune and Neutralization Antibody Seroprevalence Analysis in Blood Donors for Future Potential Pandemic Readiness
Ashish Jain, Gita Negi, Daljit Kaur, et al.
Cureus (2024)
Open Access | Times Cited: 1
Ashish Jain, Gita Negi, Daljit Kaur, et al.
Cureus (2024)
Open Access | Times Cited: 1
From the Public Health Perspective: a Scalable Model for Improving Epidemiological Testing Efficacy in Low- and Middle-Income Areas
Xuefeng Huang, Qian-Yi Kong, Xiaowen Wan, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e55194-e55194
Open Access | Times Cited: 1
Xuefeng Huang, Qian-Yi Kong, Xiaowen Wan, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e55194-e55194
Open Access | Times Cited: 1
Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection
Jane Shaw, Stephanus T. Malherbe, Gerhard Walzl, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Jane Shaw, Stephanus T. Malherbe, Gerhard Walzl, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in children and adolescents in Delhi, India, from January to October 2021: a repeated cross-sectional analysis
Pragya Sharma, Saurav Basu, Suruchi Mishra, et al.
Osong Public Health and Research Perspectives (2022) Vol. 13, Iss. 3, pp. 184-190
Open Access | Times Cited: 7
Pragya Sharma, Saurav Basu, Suruchi Mishra, et al.
Osong Public Health and Research Perspectives (2022) Vol. 13, Iss. 3, pp. 184-190
Open Access | Times Cited: 7
A Bioinformatics Tool for Predicting Future COVID-19 Waves Based on a Retrospective Analysis of the Second Wave in India: Model Development Study
Ashutosh Kumar, Adil Asghar, Prakhar Dwivedi, et al.
JMIR Bioinformatics and Biotechnology (2022) Vol. 3, Iss. 1, pp. e36860-e36860
Open Access | Times Cited: 7
Ashutosh Kumar, Adil Asghar, Prakhar Dwivedi, et al.
JMIR Bioinformatics and Biotechnology (2022) Vol. 3, Iss. 1, pp. e36860-e36860
Open Access | Times Cited: 7
Control Strategies for the COVID-19 Infection Wave in India: A Mathematical Model Incorporating Vaccine Effectiveness
Namitha Sivadas, Pooja Panda, Ashutosh Mahajan
IEEE Transactions on Computational Social Systems (2022) Vol. 10, Iss. 6, pp. 3262-3272
Open Access | Times Cited: 5
Namitha Sivadas, Pooja Panda, Ashutosh Mahajan
IEEE Transactions on Computational Social Systems (2022) Vol. 10, Iss. 6, pp. 3262-3272
Open Access | Times Cited: 5
High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India
Bhaskar Kante, Sudheer K. Vuyyuru, Ritu Gupta, et al.
Indian Journal of Gastroenterology (2023) Vol. 42, Iss. 1, pp. 70-78
Open Access | Times Cited: 2
Bhaskar Kante, Sudheer K. Vuyyuru, Ritu Gupta, et al.
Indian Journal of Gastroenterology (2023) Vol. 42, Iss. 1, pp. 70-78
Open Access | Times Cited: 2
Seroprevalence of IgG and IgM Antibodies against SARS-CoV-2 Infection in Inhabitants of Itanagar Capital Region, Arunachal Pradesh, India
Hage Nobin, Jyothinath Kothapalli, Moji Jini, et al.
MAEDICA – a Journal of Clinical Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Hage Nobin, Jyothinath Kothapalli, Moji Jini, et al.
MAEDICA – a Journal of Clinical Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Who is missed in a community-based survey: Assessment and implications of biases due to incomplete sampling frame in a community-based serosurvey, Choma and Ndola Districts, Zambia, 2022
Natalya Kostandova, Simon Mutembo, Christine Prosperi, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 4, pp. e0003072-e0003072
Open Access
Natalya Kostandova, Simon Mutembo, Christine Prosperi, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 4, pp. e0003072-e0003072
Open Access
Detection of IgG antibodies against the receptor binding domain of the spike protein and nucleocapsid of SARS-CoV-2 at university students from Southern Mexico: a cross-sectional study
Jesús Adolfo Bailón-Cuenca, Karen Cortés-Sarabia, José Legorreta-Soberanis, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Jesús Adolfo Bailón-Cuenca, Karen Cortés-Sarabia, José Legorreta-Soberanis, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Seroprevalence of SARS-CoV-2 IgG antibodies among rural children aged 6-14 years in a selected block of West Bengal, India
Vineeta Shukla, Vivek V. Shukla, Mausumi Basu, et al.
IMC Journal of Medical Science (2024), pp. 1-8
Open Access
Vineeta Shukla, Vivek V. Shukla, Mausumi Basu, et al.
IMC Journal of Medical Science (2024), pp. 1-8
Open Access
Assessment of Antibody Titers after 6 Months of Vaccination against SARS-COV-2 in Patients with CKD Stage 4, 5 and CKD 5d
Dr. Md Farucul Hasan, Prof. Dr. Md. Nazrul Islam, Abu Saleh Ahmed, et al.
Saudi Journal of Medical and Pharmaceutical Sciences (2024) Vol. 10, Iss. 07, pp. 436-446
Open Access
Dr. Md Farucul Hasan, Prof. Dr. Md. Nazrul Islam, Abu Saleh Ahmed, et al.
Saudi Journal of Medical and Pharmaceutical Sciences (2024) Vol. 10, Iss. 07, pp. 436-446
Open Access
Seroprevalence of SARS-CoV-2 antibodies in children with nephrotic syndrome and chronic kidney disease: a cross-sectional study from India
Richa Singh, Mukta Mantan, Akanksha Mahajan, et al.
Pediatric Nephrology (2024)
Closed Access
Richa Singh, Mukta Mantan, Akanksha Mahajan, et al.
Pediatric Nephrology (2024)
Closed Access